Additionally, the enhanced anti-tumor effects seen by combining anti-PD-1/PD-L1 with ARG inhibitors or arginine supplementation demonstrate that altering tumor metabolism could have profound effects on the efficacy of ICB. This evidence concerns the gene PDCD1 and neoplasm.